Hi @Watmighthavben
I read your post before you withdrew it, looked great to me. Thanks for your contribution as always.
I've been pondering something and would value your opinion, and any others for that matter. I've watched the latest ASX investor Channel interview with Yuman Fong about 5 times and it gets better each time. One thing I noticed is that Yuman say's towards the end of the interview how much he likes working with Imugene because it feels like a true partnership. He says this twice and it's obviously very important to him.
I'm wondering if he would have put any conditions on the licensing arrangement that stipulate that it CF33 can't just be sold to big pharma and buried, it must be made available to all cancer patients, therefore making a licensing deal much more likely.
Am I overthinking this?
BTW 'm still trying to get my head around the possibility that this could be developed into a vaccine that you take before you even get cancer. Truly mind-blowing.
- Forums
- ASX - By Stock
- IMU
- Why IMU is a multi multi bagger
Why IMU is a multi multi bagger, page-7587
-
- There are more pages in this discussion • 19,844 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $357.0M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.7¢ | $379.2K | 7.937M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 3773908 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 1293222 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 3552632 | 0.047 |
23 | 3044504 | 0.046 |
30 | 3803872 | 0.045 |
40 | 6966738 | 0.044 |
29 | 3216810 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 688107 | 6 |
0.049 | 3497564 | 11 |
0.050 | 6853048 | 24 |
0.051 | 2446049 | 14 |
0.052 | 1856295 | 13 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online